# Cabaletta Bio (CABA) — Earnings

CABA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/caba/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.44 |
| EPS estimate | −$0.47 |
| EPS surprise | +6.72% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1759138/000119312525273280/caba-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$0.47 | −$0.44 | 6.72% | — | — |
| Q2 2025 | Aug 7, 2025 | −$0.65 | −$0.73 | -12.39% | $4.2M | — |
| Q1 2025 | May 15, 2025 | −$0.65 | −$0.71 | -8.53% | — | — |
| Q4 2024 | Mar 31, 2025 | −$0.64 | −$0.65 | -1.71% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.60 | −$0.62 | -3.99% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.55 | −$0.56 | -2.25% | — | — |
| Q1 2024 | May 15, 2024 | −$0.48 | −$0.51 | -7.28% | — | — |
| Q4 2023 | Mar 21, 2024 | −$0.39 | −$0.46 | -17.14% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.40 | −$0.37 | 8.30% | — | — |
| Q2 2023 | Aug 10, 2023 | −$0.44 | −$0.37 | 15.91% | — | — |
| Q1 2023 | May 11, 2023 | −$0.48 | −$0.45 | 6.25% | — | — |
| Q4 2022 | Mar 16, 2023 | −$0.47 | −$0.52 | -11.04% | — | — |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.39 | 13.33% | — | — |
| Q2 2022 | Aug 11, 2022 | −$0.53 | −$0.45 | 14.56% | — | — |
| Q1 2022 | May 12, 2022 | −$0.59 | −$0.45 | 24.15% | — | — |
| Q4 2021 | Mar 17, 2022 | −$0.60 | −$0.49 | 18.14% | — | — |
| Q3 2021 | Nov 1, 2021 | −$0.50 | −$0.45 | 10.36% | — | — |
| Q2 2021 | Aug 5, 2021 | −$0.48 | −$0.45 | 7.02% | — | — |
| Q1 2021 | May 3, 2021 | −$0.49 | −$0.41 | 15.90% | — | — |
| Q4 2020 | Mar 16, 2021 | −$0.38 | −$0.40 | -4.17% | — | — |

## Frequently Asked Questions

### When did Cabaletta Bio (CABA) last report earnings?

Cabaletta Bio last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did CABA beat earnings estimates?

Yes. Cabaletta Bio reported EPS of −$0.44 for Q3 2025 against a −$0.47 estimate — a 6.72% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).